Skip to content

Author

M. Shadman

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Sep 2026

TP53-Altered Aggressive Large B-Cell Lymphoma (LBCL) Outcomes by Treatment Modality: A Multicenter Cohort From 14 US Centers.

Advances in the treatment of large B-cell lymphoma (LBCL) have expanded therapeutic options beyond conventional chemoimmunotherapy to include cellular and targeted therapies. There is growing interest in identifying subsets of LBCL that may benefit from these novel approaches based on histopathologic and molecular feat...

C. Duarte, G. Bosma, Diana Abbott et al. · 0 citations
Open access Sep 2026

Association between patient-reported symptoms and clinical outcomes in R/R CLL.

The ALPINE trial was a randomized, open-label study comparing the efficacy and safety of zanubrutinib versus ibrutinib monotherapy in patients with relapsed/refractory chronic lymphocytic leukemia/small lymphocytic lymphoma (R/R CLL/SLL). Using patient-reported outcome (PRO) data from the ALPINE trial, the current stud...

Timothy Victor, Gisoo Barnes, M. Shadman et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.